Erythromycin

Description

1. Product Overview

Erythromycin is a macrolide antibiotic widely used in pharmaceutical manufacturing for its broad-spectrum antibacterial activity, particularly against Gram-positive bacteria and certain Gram-negative organisms. It serves as a critical active pharmaceutical ingredient (API) in the production of oral, topical, and injectable formulations. The product delivers high therapeutic efficacy with a well-established safety profile, making it a cornerstone in global anti-infective drug portfolios. Strategically, erythromycin remains essential in both human and veterinary medicine, especially in regions where cost-effective, reliable antibiotics are in high demand. Its continued relevance is driven by its versatility, regulatory acceptance, and strong market demand across emerging and developed economies.

2. Key Specifications & Technical Characteristics

• Chemical Composition: Erythromycin base (C₃₇H₆₇NO₁₃), macrolide antibiotic derived from Saccharopolyspora erythraea
• Purity/Grade: ≥ 95% (USP/EP/BP compliant pharmaceutical grade available)
• Physical Form: Crystalline powder
• Color: White to off-white
• Solubility: Slightly soluble in water; soluble in alcohol and organic solvents
• Particle Size: Customizable (micronized grades available upon request)
• Odor: Odorless to faint characteristic odor
• Packaging Options:
  • 25 kg fiber drums with double inner polyethylene lining
  • Customized bulk packaging available for large-scale buyers
• Shelf Life: 24–36 months when stored in a cool, dry, and light-protected environment

3. Core Industrial Applications

Erythromycin is extensively utilized in the pharmaceutical industry for the formulation of antibiotics targeting respiratory tract infections, skin infections, and sexually transmitted diseases. It is also widely used in veterinary medicine for livestock disease management and growth promotion (regulated markets only).

In manufacturing, erythromycin functions as a key API in tablets, capsules, suspensions, and topical formulations. Its effectiveness against penicillin-resistant strains makes it a valuable alternative in treatment protocols. Compared to other antibiotics, erythromycin offers a strong balance between efficacy and tolerability, with well-documented pharmacokinetics and global regulatory acceptance.

Operationally, it enhances production efficiency due to its stability in formulation processes and compatibility with multiple dosage forms. Its cost-effectiveness and broad applicability make it a preferred choice for high-volume pharmaceutical production.

4. Competitive Advantages

• Quality Consistency: Manufactured under stringent GMP-compliant processes ensuring batch-to-batch uniformity
• Supply Reliability: Scalable production capacity supporting long-term, high-volume contracts
• Logistics Capability: Global export experience with optimized shipping solutions and documentation support
• Price Competitiveness: Economies of scale enable competitive pricing for bulk procurement
• Regulatory Compliance: Meets major pharmacopeia standards (USP, EP, BP) for global market access
• Sustainability: Efficient fermentation-based production with controlled environmental impact
• Technical Support: Full documentation package available, including COA, MSDS, DMF support (where applicable)

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20 MT
• Loading Capacity:
  • Approx. 16–20 MT per 20-ft container (depending on packaging and destination requirements)